Followers | 6 |
Posts | 2155 |
Boards Moderated | 0 |
Alias Born | 11/26/2014 |
Monday, February 19, 2018 11:49:19 AM
1. Smart Pharma will have no involvement with IPCI. It appears they may be in the market of creating/ selling drugs for specific ailments/conditions in Africa. These types of products have nothing to do with IPCI's core business of controlled release drugs. Dr. Odidi may or may not have some involvement with this company. But it does not matter as they are not a competitor to IPCI.
2. Partnerships. I believe IPCI is looking for various manufacturing and possibly marketing partners in China. I believe an Obvious one is Shanghai Yunfeng Pharmaceuticals. I believe this company would be a good fit to manufacture Gluco and Keppra at the pricepoint it need to be manufactured to compete. Could be other companies they are looking into, but this is one they obviously have ties to, so you figure it out...
3. Contract manufacturing. Same as number 2. They are looking for someone to manufacture generics at low cost for all markets. I believe this is Shanghai Yunfeng.
4. Raw Materials Sourcing. IPCI has also been looking for lower cost sources for raw materials in China. I believe first intent is to get these materials shipped to Toronto. So that they can produce, Seroquel, etc. for lower costs. I am guessing this source for raw materials is Shanghai Yunfeng source. But don't be surprised if when they partner with Shanghai Yunfeng that Seroquel production also moves to China. One again at Shanghai Yunfeng Pharmaceuticals.
That pretty much sums up my opinions...
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IPCI • PR Newswire (Canada) • 06/08/2023 05:30:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - IPCI • PR Newswire (Canada) • 06/08/2023 05:28:00 PM
- Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results • PR Newswire (Canada) • 06/06/2023 10:00:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM